查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1993815

醫藥中心和病患准入支援服務市場：全球產業分析、市場規模、市場佔有率及按服務交付方式、支付方、服務類型、適應症、國家和地區分類的預測（2025年至2032年）

Pharma Hub and Patient Access Support Service Market, By Service Delivery Type, By Payer Type, By Service Type, By Indication, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 353 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年，醫藥中心和病患准入支援服務的市場規模價值為 33.6787 億美元，預計從 2025 年到 2032 年將以 7.58% 的複合年成長率成長。

醫藥中心和患者准入支援服務市場是一個專業的外包服務生態系統，旨在幫助製藥公司簡化患者入院流程、報銷流程導航、治療依從性管理以及後續支持，尤其針對專科藥物和高價藥物。報銷框架和專科藥物日益複雜化是推動成長要素，也促使製藥商確保患者能更快獲得治療。人工智慧驅動的病人參與平台和數位化個案管理工具的整合是關鍵趨勢。然而，嚴格的資料隱私法規和支付系統的碎片化構成了阻礙因素。同時，生物製藥產品線的拓展和基於價值的醫療模式的興起，為全球範圍內先進的、以結果為導向的患者准入解決方案創造了巨大的機會。

醫藥中心和病人准入支援服務市場 - 市場動態

製藥業的擴張正在推動醫藥中心和病患准入支援服務市場的成長。

預計對藥品日益成長的需求將推動醫藥中心和患者准入支持服務市場的發展。隨著藥品生產、就業和研發投入的持續成長，進入市場的專科和高價療法數量顯著增加。這種擴張帶動了對系統化病患入院流程、報銷支援、治療依從性計畫和財務支援服務的需求。例如，代表歐洲研發製藥業的比利時行業協會——歐洲製藥商協會（EFPIA）報告稱，預計到2025年，歐洲製藥業產值將從2023年的約4381.6億美元增至2024年的約4752億美元，研發支出也將相應成長。此產業擴張將直接增加對綜合性患者准入和中心支援服務的需求，從而確保及時啟動治療並改善患者預後。

醫藥樞紐和病患准入支援服務市場 - 市場細分分析：

全球醫藥中心和病患准入支援服務市場按服務交付模式、支付方類型、服務類型、適應症和地區進行細分。

預計到2026年，專案註冊領域將佔據市場的大部分佔有率。計畫註冊是指將患者登記到特定計畫中，這些計畫旨在為他們提供所需的醫療服務、藥物或支持，以幫助他們管理自身健康。對客製化解決方案日益成長的需求以及改善患者治療效果的願望正在推動患者註冊服務的需求。多家公司正在推出新的專案註冊解決方案，這將有助於市場成長。例如，輝瑞公司於2022年12月發布了“輝瑞PAP印度版”，這是一款行動應用程式，旨在簡化和加快其患者准入計劃（PAP）的註冊流程。輝瑞公司經營十多個項目，為接受治療的患者提供支援。

預計到2026年，整合服務將主導市場。隨著複雜藥物的上市以及有效市場進入變得至關重要，製造商正在尋求綜合方法來簡化其服務。整合解決方案提供了一個統一的平台，用於管理患者准入、報銷支援和藥房協作等各種功能。為了應對產品生命週期的複雜性，領先的製造商正在擴展其服務範圍。 Terebellum（AscellaHealth）計劃於2023年3月擴展其面向生命科學製造商的HUB/患者支援服務。這些服務將有助於患者獲得藥物、提高藥物依從性並改善治療效果。 Terebellum的外包解決方案被廣泛認為是業界最佳。

醫藥樞紐和病患准入支援服務市場—區域洞察

預計到2026年，歐洲醫藥中心和病患准入支援服務市場將佔據相當大的收入佔有率。作為已開發地區，歐洲擁有較高的醫療保健支出能力，從而帶動了對醫藥中心和病患准入支援服務需求的成長。此外，隨著歐洲老年人口的成長，目標疾病的盛行率也預計將上升，進一步增加該地區對患者准入支援服務的需求。英國醫藥中心和病患准入支援服務市場預計在預測期內將顯著成長。由於英國優先發展數位醫療並加大對研發創新的投入，醫藥中心和病患准入支援服務在推動臨床研究和改善病患預後方面預計將發揮越來越重要的作用。

德國醫藥中心及病患准入支援服務市場—國家概況

2026年，德國的醫藥中心和病患准入支援服務市場在歐洲地區佔據主導地位。在德國，以病人為中心的醫療保健和臨床研究方法正日益受到重視。根據Cardinal Health在2022年發表的一篇報導，超過90%的醫師表示，預先核准流程導致患者照護延誤。由於情況複雜，約37%的醫生放棄了申請。為了確保患者能夠獲得並繼續接受治療，需要諸如eBV和ePA等技術解決方案來縮短預先核准和電子福利申請的處理時間。

目錄

第1章：醫藥中心和病人准入支援服務市場概述

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章：醫藥中心和病人准入支援服務的關鍵市場趨勢

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 未來市場趨勢

第4章：醫藥中心和病人准入支持服務業的分析

  • PEST分析
  • 波特五力分析
  • 市場成長前景展望圖
  • 管理體制分析

第5章：醫藥中心與病人進入支援服務市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：醫藥中心和病人准入支援服務的市場趨勢

  • 2024年醫藥中心和病人准入支持服務市場佔有率分析
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

第7章 醫藥中心與病人進入支援服務市場：依服務提供方式分類

  • 概述
    • 細分市場佔有率分析：依服務交付方式分類
    • 獨立服務
    • 綜合服務

第8章 醫藥中心與病人進入支援服務市場：依支付方類型分類

  • 概述
    • 細分市場佔有率分析：依支付方類型分類
    • 聯邦醫療保險
    • 私人保險
    • 自費
    • 公共保險
    • 醫療補助

第9章 醫藥中心及病人進入支援服務市場：依服務類型分類

  • 概述
    • 基於細分市場的市場佔有率分析：按服務類型
    • 臨床教育者
    • 治療導航員
      • 業務流程和標準作業程式
      • 護理團隊培訓
      • 節目資料和劇本
      • 系統測試與最佳化
    • 專案註冊
      • 註冊便利性（可透過電話、親自​​前往、入口網站或應用程式）
      • 訂單處理
      • 應用程式處理
      • 程式數據
    • 報銷服務/減輕經濟負擔服務
    • 在專業藥房進行配藥/分發
    • 其他

第10章 醫藥中心與病人進入支持服務市場：依適應症分類

  • 概述
    • 細分市場佔有率分析：依支付方類型分類
    • 腫瘤學
    • 呼吸系統疾病
    • 罕見疾病
    • 心血管疾病
    • 自體免疫疾病
    • 消化系統疾病

第11章 醫藥中心和病人准入支援服務市場：按地區分類

  • 介紹
  • 北美洲
    • 概述
    • 主要製造商：北美
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 主要製造商：歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 概述
    • 主要製造商：亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 其他亞太國家
  • 拉丁美洲
    • 概述
    • 主要製造商：拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他拉丁美洲國家
  • 中東和非洲
    • 概述
    • 主要生產商：中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 其他中東和非洲國家

第12章 主要供應商分析：醫藥中心與病患准入支援服務業

  • 競爭基準
    • 競爭對手儀錶板
    • 競爭定位
  • 公司簡介
    • McKesson Corporation
    • Valeris（Formerly PharmaCord）
    • Cardinal Health
    • Envoy Health, Inc
    • EVERSANA
    • Fortrea
    • Mercalis
    • Sciensus
    • AssistRx
    • Lash Group
    • Engage
    • CareMetx, LLC
    • ConnectiveRx.
    • NS Pharma, Inc.（a wholly owned subsidiary of Nippon Shinyaku Co., Ltd.）
    • United BioSource LLC
    • Others

第13章：AnalystView 的全景視圖

簡介目錄
Product Code: ANV6155

Pharma Hub and Patient Access Support Service Market size was valued at US$ 3,367.87 Million in 2024, expanding at a CAGR of 7.58% from 2025 to 2032.

The Pharma Hub and Patient Access Support Service Market is a specialized ecosystem of outsourced services that assists pharmaceutical companies in streamlining patient onboarding, reimbursement navigation, therapy adherence, and ongoing support, especially for specialty and high-cost drugs. The increasing complexity of reimbursement frameworks and specialty therapeutics is a major growth driver, putting pressure on manufacturers to ensure faster therapy access. The integration of AI-powered patient engagement platforms with digital case management tools is a key trend. However, stringent data privacy regulations and fragmented payer systems serve as constraints. At the same time, expanding biologics pipelines and value-based care models present significant opportunities for advanced, outcome-focused patient access solutions around the world.

Pharma Hub and Patient Access Support Service Market- Market Dynamics

Rising Pharmaceutical Industry Expansion Driving Growth in Pharma Hub and Patient Access Support Services Market

The growing demand for pharmaceutical products is expected to fuel growth in the Pharma Hub and Patient Access Support Service Market. As pharmaceutical production, employment, and R&D investments continue to rise, the number of specialty and high-cost therapies entering the market grows significantly. This expansion increases the demand for structured patient onboarding, reimbursement assistance, therapy adherence programs, and financial support services. For example, in 2025, the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgian trade association that represents Europe's research-based pharmaceutical industry, reported that production in Europe increased from approximately $438.16 billion in 2023 to an estimated $475.2 billion in 2024, accompanied by increased R&D spending. Such industry expansion directly increases demand for comprehensive patient access and hub support services, which ensure timely therapy initiation and better patient outcomes.

Pharma Hub and Patient Access Support Service Market- Segmentation Analysis:

The Global Pharma Hub and Patient Access Support Service Market is segmented by Service Delivery Type, Payer Type, Service Type, Indication, and Region.

In 2026, the program enrollment segment will account for the majority of the share. Program enrollment is the process of registering patients in specific programs that aim to provide them with access to healthcare services, medications, or support needed to manage their health conditions. The growing demand for customized solutions, as well as the desire to improve patient outcomes, drives the demand for patient enrollment services. Several companies are launching new program enrollment solutions, which will help the market grow. For example, in December 2022, Pfizer Inc. launched 'Pfizer PAP India,' a mobile application that facilitates and expedites enrollment in Pfizer's Patient Access Programmes (PAP). Pfizer ran over ten programs to help patients undergoing treatments.

In 2026, integrated services will dominate the market. Manufacturers are seeking a comprehensive approach to streamline their services as complex pharmaceutical products are introduced and effective market access is required. Integrated solutions provide a unified platform for managing various functions such as patient access, reimbursement assistance, and pharmacy coordination. To deal with the complexities of the product lifecycle, key manufacturers are expanding their offerings. Terebellum (AscellaHealth) will expand its life sciences manufacturers' HUB/patient support services in March 2023. These services promote patient access to medication, compliance, and improved outcomes. Terebellum's outsourced solutions are widely regarded as best in class.

Pharma Hub and Patient Access Support Service Market- Geographical Insights

In 2026, the pharma HUB and patient access support service market in Europe accounts for a significant revenue share. As a developed region, Europe has greater healthcare spending power, increasing demand for pharma HUB and patient access support services. Furthermore, as Europe's geriatric population grows, the prevalence of target diseases is expected to rise, increasing demand for patient access support services in the region. The UK pharma HUB and patient access support service market is expected to expand significantly over the forecast period. As the UK prioritizes digital health and invests in research and innovation, pharma HUBs and patient access support services are expected to become increasingly important in advancing clinical research and improving patient outcomes.

Germany Pharma Hub and Patient Access Support Service Market- Country Insights

In 2026, the German pharma HUB and patient access support service market dominated the European region. The country is increasingly focusing on patient-centered approaches to healthcare and clinical research. According to a 2022 article published by Cardinal Health, the prior authorization process causes patient care delays for more than 90% of physicians. Due to the complexities of the situation, approximately 37% of these physicians have abandoned requests. To ensure that patients have access to and remain on therapies, technology solutions such as eBV and ePA must be used to reduce onboarding time for both prior authorizations and electronic benefit investigations.

Pharma Hub and Patient Access Support Service Market- Competitive Landscape:

The pharma hub and patient access support service market is highly competitive, driven by the need to improve patient outcomes, accelerate therapy access, and enhance patient engagement across complex treatment pathways. Key service providers differentiate through comprehensive support offerings such as reimbursement assistance, financial support programs, patient education platforms, and digital care coordination tools. Partnerships with pharmaceutical manufacturers, payers, and specialty pharmacies are crucial to expanding service reach and ensuring seamless care delivery. Companies also focus on leveraging data analytics and AI to optimize patient identification, adherence monitoring, and outcome tracking. Prominent players in this space include Patient Connect, Innomar Strategies, Accredo Health Group (Express Scripts), and McKesson Corporation, each leveraging broad healthcare networks and integrated support solutions to strengthen market positioning.

Recent Developments:

In March 2025, Valeris is one of the largest independent patient access solution providers in the biopharmaceutical industry, having been formed by the merger of PharmaCord and Mercalis. This merger brings together PharmaCord's expertise in patient services and Mercalis' comprehensive commercialization solutions to improve patient access, affordability, therapy adherence, and overall healthcare delivery. The new organization intends to streamline the commercialization process and improve outcomes for patients and life science companies worldwide.

In June 2023, Labcorp announced the spin-off of Fortrea. Fortrea is now an independent CRO providing patient access, Phase I-IV clinical trial management, and technology solutions to biotechnology and pharmaceutical companies worldwide. This strategic move is expected to improve the company's ability to meet customer needs, unlock shareholder value, and make targeted value-creating investments.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as following:

GLOBAL PHARMA HUB AND PATIENT ACCESS SUPPORT SERVICE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • McKesson Corporation
  • Valeris (Formerly PharmaCord)
  • Cardinal Health
  • Envoy Health, Inc
  • EVERSANA
  • Fortrea
  • Mercalis
  • Sciensus
  • AssistRx
  • Lash Group
  • Engage
  • CareMetx, LLC
  • ConnectiveRx.
  • NS Pharma, Inc. (a wholly owned subsidiary of Nippon Shinyaku Co., Ltd.)
  • United BioSource LLC
  • Others

GLOBAL PHARMA HUB AND PATIENT ACCESS SUPPORT SERVICE MARKET, BY SERVICE DELIVERY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Standalone Services
  • Integrated Services

GLOBAL PHARMA HUB AND PATIENT ACCESS SUPPORT SERVICE MARKET, BY PAYER TYPE- MARKET ANALYSIS, 2019 - 2032

  • Medicare
  • Commercial Insurance
  • Self-Pay
  • Government Insurance
  • Medicaid

GLOBAL PHARMA HUB AND PATIENT ACCESS SUPPORT SERVICE MARKET, BY SERVICE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Clinical Educator
  • Treatment Navigators
  • Process flows and standard operating procedures
  • Care team training
  • Program literature and scripts
  • Systems testing and optimization
  • Program Enrolment
  • Ease of enrollment (through phone, face, portal, or app)
  • Order processing
  • Application processing
  • Program data
  • Reimbursement Services/Affordability Services
  • Coordination of Specialty Pharmacy/Dispensing
  • Others

GLOBAL PHARMA HUB AND PATIENT ACCESS SUPPORT SERVICE MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032

  • Oncology
  • Respiratory Diseases
  • Rare Diseases
  • Cardiovascular Diseases
  • Autoimmune Disorders
  • Gastrointestinal Diseases

GLOBAL PHARMA HUB AND PATIENT ACCESS SUPPORT SERVICE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Pharma Hub and Patient Access Support Service Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Pharma Hub and Patient Access Support Service Market Snippet by Service Delivery Type
    • 2.1.2. Pharma Hub and Patient Access Support Service Market Snippet by Payer Type
    • 2.1.3. Pharma Hub and Patient Access Support Service Market Snippet by Service Type
    • 2.1.4. Pharma Hub and Patient Access Support Service Market Snippet by Indication
    • 2.1.5. Pharma Hub and Patient Access Support Service Market Snippet by Country
    • 2.1.6. Pharma Hub and Patient Access Support Service Market Snippet by Region
  • 2.2. Competitive Insights

3. Pharma Hub and Patient Access Support Service Key Market Trends

  • 3.1. Pharma Hub and Patient Access Support Service Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Pharma Hub and Patient Access Support Service Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Pharma Hub and Patient Access Support Service Market Opportunities
  • 3.4. Pharma Hub and Patient Access Support Service Market Future Trends

4. Pharma Hub and Patient Access Support Service Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Pharma Hub and Patient Access Support Service Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Pharma Hub and Patient Access Support Service Market Landscape

  • 6.1. Pharma Hub and Patient Access Support Service Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Pharma Hub and Patient Access Support Service Market - By Service Delivery Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Service Delivery Type, 2024 & 2032 (%)
    • 7.1.2. Standalone Services
    • 7.1.3. Integrated Services

8. Pharma Hub and Patient Access Support Service Market - By Payer Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Payer Type, 2024 & 2032 (%)
    • 8.1.2. Medicare
    • 8.1.3. Commercial Insurance
    • 8.1.4. Self-Pay
    • 8.1.5. Government Insurance
    • 8.1.6. Medicaid

9. Pharma Hub and Patient Access Support Service Market - By Service Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Service Type, 2024 & 2032 (%)
    • 9.1.2. Clinical Educator
    • 9.1.3. Treatment Navigators
      • 9.1.3.1. Process flows and standard operating procedures
      • 9.1.3.2. Care team training
      • 9.1.3.3. Program literature and scripts
      • 9.1.3.4. Systems testing and optimization
    • 9.1.4. Program Enrolment
      • 9.1.4.1. Ease of enrollment (through phone, face, portal, or app)
      • 9.1.4.2. Order processing
      • 9.1.4.3. Application processing
      • 9.1.4.4. Program data
    • 9.1.5. Reimbursement Services/Affordability Services
    • 9.1.6. Coordination of Specialty Pharmacy/Dispensing
    • 9.1.7. Others

10. Pharma Hub and Patient Access Support Service Market - By Indication

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Payer Type, 2024 & 2032 (%)
    • 10.1.2. Oncology
    • 10.1.3. Respiratory Diseases
    • 10.1.4. Rare Diseases
    • 10.1.5. Cardiovascular Diseases
    • 10.1.6. Autoimmune Disorders
    • 10.1.7. Gastrointestinal Diseases

11. Pharma Hub and Patient Access Support Service Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Pharma Hub and Patient Access Support Service Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Pharma Hub and Patient Access Support Service Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Pharma Hub and Patient Access Support Service Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Pharma Hub and Patient Access Support Service Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Pharma Hub and Patient Access Support Service Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Pharma Hub and Patient Access Support Service Industry

  • 12.1. Competitive Benchmarking
    • 12.1.1. Competitive Dashboard
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. McKesson Corporation
    • 12.2.2. Valeris (Formerly PharmaCord)
    • 12.2.3. Cardinal Health
    • 12.2.4. Envoy Health, Inc
    • 12.2.5. EVERSANA
    • 12.2.6. Fortrea
    • 12.2.7. Mercalis
    • 12.2.8. Sciensus
    • 12.2.9. AssistRx
    • 12.2.10. Lash Group
    • 12.2.11. Engage
    • 12.2.12. CareMetx, LLC
    • 12.2.13. ConnectiveRx.
    • 12.2.14. NS Pharma, Inc. (a wholly owned subsidiary of Nippon Shinyaku Co., Ltd.)
    • 12.2.15. United BioSource LLC
    • 12.2.16. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us